BioSpace News Archive

Zenas BioPharma announced it has launched a cross-border biopharmaceutical company based in both China and the U.S.

It’s March Madness in the life sciences industry, with money pouring in faster than LeBron James on a breakaway. Here’s where the big bucks went this week.

Targeted immunotherapy company Asher Bio launched today with a $55 million Series A round led by Third Rock Ventures, aiming to move its lead engineered interleukin-2 (IL-2) therapy into human testing next year.

Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the expansion of its senior management team by appointing Dr. Xichen Zhang as Senior Vice President of Manufacturing and Dr. Steven Yu

AVEO Oncology announced that it has priced its previously announced underwritten public offering of 6,000,000 shares of its common stock at a price to the public of $8.00 per share.

CLINUVEL has expanded its clinical program to evaluate the DNA reparative potential of afamelanotide in skin cells which have been damaged by ultraviolet (UV) and sun exposure.

Promega Biotech Ibérica has been recognized as a business leader in Spain for the biotechnology company’s COVID-19 response.

Ketorolac is an anti-inflammatory drug that is used to treat short-term, moderate to severe pain. Ketorolac is prescribed before or after medical procedures such as surgery.

Increasing demand for pharmaceutical containers and biohazard containers to create wide opportunities for medical waste containers market

Unither Pharmaceuticals, the Blow-Fill-Seal worldwide leader, provides diagnostic companies with capacity solutions and innovative technologies for their testing kits.